Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Tsuchiya

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 23, 2014
Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complicationsYuka Takahashi, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 15, 2007
Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitisHiroko Iijima, Fuminori Moriyasu, Kaoru Tsuchiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 13, 2015
Proposal of Japan Red Cross score for sorafenib therapy in hepatocellular carcinomaHaruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, et al.
Journal of Cancer|June 26, 2014
Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in JapanHiroki Nishikawa, Haruhiko Takeda, Kaoru Tsuchiya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 20, 2014
Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in JapanHaruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 16, 2014
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinomaKaoru Tsuchiya, Yasuhiro Asahina, Nobuharu Tamaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 5, 2005
[A case of advanced gastric cancer acquired long-term response two years or more by treatment with oral anticancer drug TS-1]Jun Itakura, Namiki Izumi, Kazunari Inoue, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 6, 2005
Serum KL-6 as a novel tumor marker for hepatocellular carcinoma in hepatitis C virus infected patientsMasayuki Kurosaki, Namiki Izumi, Yuko Onuki, et al.
International Journal of Oncology|September 19, 2014
Comparison of standard-dose and half‑dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysisHiroki Nishikawa, Yukio Osaki, Masatsugu Endo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2024
Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction-associated steatotic liver diseaseNobuharu Tamaki, Shun-Ichi Wakabayashi, Takefumi Kimura, et al.
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 23, 2014
Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complicationsYuka Takahashi, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 15, 2007
Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitisHiroko Iijima, Fuminori Moriyasu, Kaoru Tsuchiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 13, 2015
Proposal of Japan Red Cross score for sorafenib therapy in hepatocellular carcinomaHaruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, et al.
Journal of Cancer|June 26, 2014
Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in JapanHiroki Nishikawa, Haruhiko Takeda, Kaoru Tsuchiya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 20, 2014
Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in JapanHaruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 16, 2014
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinomaKaoru Tsuchiya, Yasuhiro Asahina, Nobuharu Tamaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 5, 2005
[A case of advanced gastric cancer acquired long-term response two years or more by treatment with oral anticancer drug TS-1]Jun Itakura, Namiki Izumi, Kazunari Inoue, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 6, 2005
Serum KL-6 as a novel tumor marker for hepatocellular carcinoma in hepatitis C virus infected patientsMasayuki Kurosaki, Namiki Izumi, Yuko Onuki, et al.
International Journal of Oncology|September 19, 2014
Comparison of standard-dose and half‑dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysisHiroki Nishikawa, Yukio Osaki, Masatsugu Endo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2024
Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction-associated steatotic liver diseaseNobuharu Tamaki, Shun-Ichi Wakabayashi, Takefumi Kimura, et al.
Pageof 15